Format

Send to

Choose Destination
See comment in PubMed Commons below
Lancet Infect Dis. 2008 Nov;8(11):698-709. doi: 10.1016/S1473-3099(08)70255-X.

Hepatitis E: an emerging infection in developed countries.

Author information

1
Peninsula College of Medicine and Dentistry, Royal Cornwall Hospital Trust, Truro, UK. harry.dalton@rcht.cornwall.nhs.uk

Abstract

Hepatitis E is endemic in many developing countries where it causes substantial morbidity. In industrialised countries, it is considered rare, and largely confined to travellers returning from endemic areas. However, there is now a growing body of evidence that challenges this notion. Autochthonous hepatitis E in developed countries is far more common than previously recognised, and might be more common than hepatitis A. Hepatitis E has a predilection for older men in whom it causes substantial morbidity and mortality. The disease has a poor prognosis in the context of pre-existing chronic liver disease, and is frequently misdiagnosed as drug-induced liver injury. The source and route of infection remain uncertain, but it might be a porcine zoonosis. Patients with unexplained hepatitis should be tested for hepatitis E, whatever their age or travel history.

PMID:
18992406
DOI:
10.1016/S1473-3099(08)70255-X
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center